R A Hazelton

513 total citations
23 papers, 370 citations indexed

About

R A Hazelton is a scholar working on Rheumatology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, R A Hazelton has authored 23 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 6 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in R A Hazelton's work include Systemic Lupus Erythematosus Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). R A Hazelton is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). R A Hazelton collaborates with scholars based in Australia, United Kingdom and United States. R A Hazelton's co-authors include D.H. Brown, W. Ewen Smith, Calum J. McNeil, B. T. Emmerson, Ian H. Frazer, R D Sturrock, Chris Hughes, J. H. Pope, R D Sturrock and Simone Cross and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Annals of the Rheumatic Diseases and Journal of General Virology.

In The Last Decade

R A Hazelton

22 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R A Hazelton Australia 11 161 70 57 47 43 23 370
Joanna Wrześniewska Poland 7 111 0.7× 60 0.9× 23 0.4× 85 1.8× 16 0.4× 8 349
Chao H. Chan United States 12 44 0.3× 48 0.7× 26 0.5× 93 2.0× 37 0.9× 16 467
K.D. Morley United Kingdom 9 137 0.9× 71 1.0× 13 0.2× 12 0.3× 18 0.4× 14 327
Allen Litwin United States 15 110 0.7× 193 2.8× 20 0.4× 33 0.7× 21 0.5× 27 538
J H van Tongeren Netherlands 11 48 0.3× 53 0.8× 20 0.4× 125 2.7× 14 0.3× 14 994
Elham Rajaei Iran 11 94 0.6× 57 0.8× 69 1.2× 32 0.7× 16 0.4× 37 366
Tomoko Hagiwara Japan 12 86 0.5× 38 0.5× 18 0.3× 47 1.0× 45 1.0× 27 378
Franklin M. Klion United States 18 37 0.2× 26 0.4× 18 0.3× 78 1.7× 50 1.2× 33 877
A C Thomsen Denmark 14 29 0.2× 74 1.1× 34 0.6× 19 0.4× 55 1.3× 33 482
José Luis Gálvez-Romero Mexico 9 134 0.8× 91 1.3× 16 0.3× 14 0.3× 42 1.0× 25 326

Countries citing papers authored by R A Hazelton

Since Specialization
Citations

This map shows the geographic impact of R A Hazelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R A Hazelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R A Hazelton more than expected).

Fields of papers citing papers by R A Hazelton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R A Hazelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R A Hazelton. The network helps show where R A Hazelton may publish in the future.

Co-authorship network of co-authors of R A Hazelton

This figure shows the co-authorship network connecting the top 25 collaborators of R A Hazelton. A scholar is included among the top collaborators of R A Hazelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R A Hazelton. R A Hazelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vecchio, Phillip & R A Hazelton. (1991). Spontaneous haemarthrosis in amyloid arthropathy of the shoulder. Australian and New Zealand Journal of Medicine. 21(3). 343–344. 2 indexed citations
2.
Hazelton, R A, et al.. (1990). Partial purification and characterisation of a synovial fluid inhibitor of osteoblasts.. Annals of the Rheumatic Diseases. 49(2). 121–124. 6 indexed citations
3.
Emmerson, B. T., R A Hazelton, & Ian H. Frazer. (1988). Some adverse reactions to allopurinol may be mediated by lymphocyte reactivity to oxypurinol. Arthritis & Rheumatism. 31(3). 436–440. 44 indexed citations
4.
Sculley, T B, Dennis Moss, R A Hazelton, & J. H. Pope. (1987). Detection of Epstein-Barr Virus Strain Variants in Lymphoblastoid Cell Lines 'Spontaneously' Derived from Patients with Rheumatoid Arthritis, Infectious Mononucleosis and Normal Controls. Journal of General Virology. 68(8). 2069–2078. 17 indexed citations
5.
Hazelton, R A. (1987). Ross River virus infection and epidemic polyarthritis.. PubMed. 16(2). 130, 133–130, 133. 1 indexed citations
6.
Whitaker, A.N., et al.. (1987). CHARACTERIZATION OF SYNOVIAL AND PLASMA FIBRIN DEGRADATION PRODUCTS IN RHEUMATOID ARTHRITIS. Thrombosis and Haemostasis. 1 indexed citations
7.
Bishop, CJ, et al.. (1986). T lymphocyte lines from arthritic synovial fluid: establishment and function.. Annals of the Rheumatic Diseases. 45(2). 120–125. 1 indexed citations
9.
Hazelton, R A, et al.. (1986). A FAMILY STUDY OF THE PREVALENCE OF ANTIBODIES TO THE RHEUMATOID ARTHRITIS ASSOCIATED NUCLEAR ANTIGEN (RANA). Lara D. Veeken. 25(4). 349–352. 4 indexed citations
10.
Hazelton, R A, et al.. (1985). THE INFLAMMATORY RESPONSE IN THE SYNOVIUM OF A PATIENT WITH ROSS RIVER ARBOVIRUS INFECTION. Australian and New Zealand Journal of Medicine. 15(3). 336–339. 38 indexed citations
11.
Cross, Simone & R A Hazelton. (1985). Correlation of disease activity and drug therapy with the autologous mixed lymphocyte reaction in rheumatoid arthritis.. Annals of the Rheumatic Diseases. 44(4). 224–231. 12 indexed citations
12.
Hazelton, R A, et al.. (1985). A REPORT OF THREE CASES OF YERSINIA REACTIVE ARTHRITIS. Australian and New Zealand Journal of Medicine. 15(3). 331–335. 3 indexed citations
13.
Hazelton, R A. (1984). A study of lymphocytotoxins in the sera of families of patients with rheumatoid disease. Arthritis & Rheumatism. 27(2). 233–236. 3 indexed citations
14.
Hazelton, R A. (1984). A study of lymphocytotoxins in families of patients with systemic lupus erythematosus.. Annals of the Rheumatic Diseases. 43(2). 136–139. 4 indexed citations
15.
Hazelton, R A, Alan B. McCruden, R D Sturrock, & W.H. Stimson. (1983). Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19-nortestosterone.. Annals of the Rheumatic Diseases. 42(2). 155–157. 22 indexed citations
16.
Hazelton, R A, et al.. (1982). Immunogenetic Insights into Rheumatoid Arthritis: A Family Study. QJM. 51(203). 336–40. 8 indexed citations
17.
Brown, D.H., et al.. (1982). Altered thiol status in patients with rheumatoid arthritis. Rheumatology International. 2(3). 107–111. 37 indexed citations
18.
Brown, D.H., et al.. (1982). Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis.. Annals of the Rheumatic Diseases. 41(5). 458–462. 48 indexed citations
19.
Hazelton, R A, et al.. (1980). Cerebral systemic lupus erythematosus: a case report and evaluation of diagnostic tests.. Journal of Neurology Neurosurgery & Psychiatry. 43(4). 357–359. 5 indexed citations
20.
Ratcliffe, W A, R A Hazelton, John A. Thomson, & J. G. Ratcliffe. (1980). THE EFFECT OF FENCLOFENAC ON THYROID FUNCTION TESTS IN VIVO AND IN VITRO. Clinical Endocrinology. 13(6). 569–575. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026